Roger Herschel Herzig: younger half of the dynamic duo which advanced leukaemia therapy and transplants: January 4, 1946 to July 18, 2020

To commemorate the life and contributions of Roger Herschel Herzig to leukaemia therapy and bone marrow transplantation.

Roger Herzig significantly advanced leukaemia therapy and bone marrow transplantation over nearly 50 years.
He was instrumental in establishing bone marrow transplant programmes internationally.
His collaborations led to the development of therapies still in use today for treating leukaemias and lymphomas.

Roger Herzig's legacy is marked by his dedication to patient care, medical education, and significant contributions to cancer treatment.

The article does not provide detailed quantitative data on the impact of Herzig's contributions.
Personal anecdotes may not fully capture the breadth of his professional achievements.

Roger Herzig's contributions to medicine and his personal qualities have left a lasting impact on the fields of haematology and oncology.